Home / National Oncology Conference / ACCC Annual Awards

ACCC Annual Awards

Annual Achievement Award

The Annual Achievement Award has been given since 1980 to distinguished individuals or organizations in a wide variety of fields, who have reflected values of community cancer care through their outstanding contributions.

headshots-hurria-dale-200x500-ver2Arti Hurria, MD, FASCO
City of Hope

The 2019 ACCC Annual Achievement Award is being presented posthumously to Arti Hurria, MD, FASCO, former George Tsai Family Chair in Geriatric Oncology, director of the Center for Cancer and Aging at City of Hope, and nationally regarded expert and advocate for elderly patients with cancer.

In 1995, Dr. Hurria began her internship at Beth Israel Medical Center, which has a strong geriatrics and oncology programs. In addition, Dr. Hurria completed a geriatrics fellowship at Harvard to bolster her skills and knowledge in treating older patients before entering her oncology fellowship at Memorial Sloan Kettering Cancer Center (MSK) in 1999, a time when the field of geriatric oncology was just beginning to emerge. It was at MSK where Dr. Hurria met another important mentor, George Bosl, MD, who was Chair of Medicine. Together, they wrote a grant to bring cancer care and geriatrics together in a comprehensive cancer center. That experience solidified Dr. Hurria’s decision to enhance the field of geriatric oncology and influenced her move to City of Hope, where she made her mark in geriatric oncology and remained for the duration of her remarkable career.

Dr. Hurria served as founding editor of the Journal of Geriatric Oncology. She was Chair and Founder of the Cancer and Aging Research Group, Co-Chair of the Alliance Cancer in the Elderly Committee, past President of the International Society of Geriatric Oncology, and past Chair of the National Comprehensive Cancer Network® (NCCN®) Older Adult Oncology Committee. She received many awards and honors, including ASCO’s B. J. Kennedy Award for Scientific Excellence in Geriatric Oncology, the International Society of Geriatric Oncology’s Paul Calabresi award, the Paul B. Beeson Career Development Award in Aging (K23), and the Frederick Steen Memorial Award for Humanism in Medicine.

William Dale, MD, PhD, co-principal investigator with Dr. Hurria on a five-year, $2 million grant from the National Institute of Aging, will accept the award on her behalf. Dr. Dale, the Arthur M. Coppola Family Chair in Supportive Care Medicine and clinical professor and chair of City of Hope's Department of Supportive Care Medicine, will provide an update on their ground-breaking research and the importance of conducting a comprehensive geriatric assessment to help address the unique needs of this growing patient population.
Learn More

 

Clinical Research Award

The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, or community.

headshot-Ethan-Basch-200x240Ethan Basch, MD, MSc
Director, Cancer Outcomes Research Program, UNC Lineberger Comprehensive Cancer Center; Professor, Hematology and Oncology; Associate Editor, Journal of the American Medical Association (JAMA).

Hear firsthand from Dr. Basch about the importance of collecting patient-reported outcomes (PROs) in routine practice to enhance clinical care. Learn about the significant findings his research has revealed, including potential survival advantages for patients.
Learn More

 

David King Community Clinical Scientist Award

The David King Community Clinical Scientist Award recognizes active community clinical research leaders who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.

headshot-Paul-Hansen-200x240Paul D. Hansen, MD, FACS
Liver and Pancreas Surgeon, Hernia Surgeon, General Surgeon, Providence St. Joseph Health, Portland, Oregon

Dr. Hansen will discuss his pioneering research in minimally invasive approaches to major liver and pancreas surgery and the promise it holds for improving the quality of care, the patient experience, and potentially reducing healthcare costs.
Learn More

 
 
 

Media Partners

logo-AJMC-290x107

logo-TargetedOncology-290x110